US Stock MarketDetailed Quotes

EDSA Edesa Biotech

Watchlist
  • 4.5500
  • +0.0300+0.66%
Close May 8 16:00 ET
  • 4.3500
  • -0.2000-4.40%
Post 18:42 ET
14.63MMarket Cap-1763P/E (TTM)

About Edesa Biotech Company

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Company Profile

SymbolEDSA
Company NameEdesa Biotech
Listing DateNov 5, 2015
Founded2007
CEODr. Pardeep Nijhawan, F.R.C.P.C,M.D.
MarketNASDAQ
Employees16
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address100 Spy Court
CityMarkham
ProvinceOntario
CountryCanada
Zip CodeL3R 5H6
Phone1-289-800-9600
Websitehttp://www.edesabiotech.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pardeep Nijhawan, F.R.C.P.C,M.D.
  • Director, Chief Executive Officer and Corporate Secretary
  • 549.56K
  • Stephen L. Lemieux
  • Chief Financial Officer and Principal Accounting Officer
  • 155.94K
  • Dr. Michael Brooks, M.B.A.,PhD
  • President
  • 488.76K
  • Carlo Sistilli, C.M.A.,C.P.A.
  • Chairman of the Board
  • 67.83K
  • Sean MacDonald
  • Independent Director
  • 68.01K
  • Joan Chypyha
  • Independent Director
  • 30.81K
  • Patrick Marshall
  • Independent Director
  • 29.20K
  • Frank R. Oakes
  • Independent Director
  • 56.37K
  • Charles V. Olson, D.Sc.
  • Independent Director
  • 28.13K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg